FindTrial
Sign In

An otorhinolaryngological tissue penetration study of T-4288

An otorhinolaryngological tissue penetration study of T-4288 in patients scheduled for surgery

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080222702
Enrollment
Unknown
Registered
2014-12-22
Start date
2014-12-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic sinusitis, chronic otitis media, chronic tonsillitis or palatine tonsil hypertrophy

Interventions

investigational material(s) Generic name etc : T-4288 INN of investigational material : solithromycin Therapeutic category code : 614 Antibiotic preparations acting mainly on gram-positive bacteria an

Sponsors

Toyama Chemical Co., Ltd.(Current FUJIFILM Toyama Chemical Co., Ltd.)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age: 20 years of age and older 2. Gender : Both 3. Other

Exclusion criteria

Exclusion criteria: 1.Have a presence of severe renal dysfunction, serious cardiovascular disorder or significant hepatic disorder 2.Have a history of allergy to macrolide antibiotics 3.Others

Design outcomes

Primary

MeasureTime frame
safety and pharmacokinetic profile—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026